Simulations Plus And 4 Other Stocks Have Very High Payout Ratio

(VIANEWS) – Entravision Communications Corporation (EVC), Luxfer Holdings PLC (LXFR), DHT Holdings (DHT) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio up until now. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. Entravision Communications Corporation (EVC)

1750% Payout Ratio

Entravision Communications Corporation operates as an advertising, media, and technology solutions company worldwide. The company operates through three segments: Digital, Television, and Audio. It reaches and engages Hispanics across acculturation levels and media channels. The company's portfolio encompasses integrated end-to-end advertising solutions, including digital, television, and audio properties. It also offers a suite of end-to-end digital advertising solutions, including digital commercial partnerships services, as well as advertising customers billing and technological and other support services, including strategic marketing and training; and Smadex, a programmatic ad purchasing platform that enables advertising customers or ad agencies to purchase advertising electronically and manage data-driven advertising campaigns through online marketplaces. In addition, the company provides a branding and mobile performance solutions, such as managed services to advertisers looking to connect with consumers on mobile devices; and digital audio advertising solutions for advertisers. Further, it sells advertisements and syndicated radio programming solutions through its Entravision radio network. As of March 3, 2022, the company had 50 television stations; and 46 Spanish-language radio stations. It serves advertisers from various industries, such as e-commerce, retail, entertainment, gaming, delivery services, financial technology, communications, lifestyle, and travel. The company was founded in 1996 and is headquartered in Santa Monica, California.

Earnings Per Share

As for profitability, Entravision Communications Corporation has a trailing twelve months EPS of $-0.75.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -27.6%.

Yearly Top and Bottom Value

Entravision Communications Corporation’s stock is valued at $2.03 at 02:23 EST, way below its 52-week high of $4.91 and way higher than its 52-week low of $1.33.

Moving Average

Entravision Communications Corporation’s worth is under its 50-day moving average of $2.11 and way under its 200-day moving average of $3.22.

2. Luxfer Holdings PLC (LXFR)

140.54% Payout Ratio

Luxfer Holdings PLC, a materials technology company, designs, manufactures, and supplies high-performance materials, components, and high-pressure gas cylinders for transportation, defense and emergency response, healthcare, and general industrial end-market applications. It operates in two segments, Gas Cylinders and Elektron. The Gas Cylinders segment manufactures and markets aluminum, titanium, and carbon composite cylinders, which are used for self-contained breathing apparatus that are used by firefighters and other emergency-responders, as well as scuba divers and personnel in potentially hazardous environments, such as mines; and aluminum and composite cylinders for use in the containment of oxygen and other medical gases that are used by patients, healthcare facilities, and laboratories. This segment also offers carbon composite cylinders for compressed natural gas and hydrogen containment in alternative fuel vehicles; lightweight aluminum cylinders for a variety of industrial applications, such as fire extinguishers and containment of high-purity specialty gases; and lightweight aluminum and titanium panels primarily for use in the aerospace and luxury-auto industries. The Elektron segment focuses on specialty materials based on magnesium, zircon sand, and rare earths. It develops and manufactures magnesium alloys; magnesium powders; and magnesium, copper, and zinc photoengraving plates for graphic arts and luxury packaging. This segment also develops and manufactures zirconium-based materials and oxides used as catalysts and in the manufacture of advanced ceramics, fiber-optic fuel cells, and other performance products. Luxfer Holdings PLC has operations in the United States, the United Kingdom, Germany, Italy, France, rest of Europe, the Asia Pacific, Canada, South America, Latin America, and Africa. The company was founded in 1898 and is headquartered in Manchester, the United Kingdom.

Earnings Per Share

As for profitability, Luxfer Holdings PLC has a trailing twelve months EPS of $-0.02.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.14%.

Volume

Today’s last reported volume for Luxfer Holdings PLC is 67753 which is 49.77% below its average volume of 134893.

Sales Growth

Luxfer Holdings PLC’s sales growth is negative 9.7% for the ongoing quarter and negative 1.7% for the next.

Yearly Top and Bottom Value

Luxfer Holdings PLC’s stock is valued at $11.15 at 02:23 EST, way under its 52-week high of $16.19 and way higher than its 52-week low of $7.55.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 11.1% and positive 425% for the next.

Previous days news about Luxfer Holdings PLC (LXFR)

  • According to Zacks on Friday, 28 June, "Given this scenario, it would be ideal to invest in four industrial stocks such as Allegion plc (ALLE Quick QuoteALLE – Free Report) , AptarGroup, Inc. (ATR Quick QuoteATR – Free Report) EnerSys (ENS Quick QuoteENS – Free Report) , Helios Technologies, Inc. (HLIO Quick QuoteHLIO – Free Report) and Luxfer Holdings PLC (LXFR Quick QuoteLXFR – Free Report) . "

3. DHT Holdings (DHT)

94.29% Payout Ratio

DHT Holdings, Inc., through its subsidiaries, owns and operates crude oil tankers primarily in Monaco, Singapore, Oslo, and Norway. As of March 17, 2021, it had a fleet of 28 very large crude carriers with a capacity of 8,660,835 deadweight tons. The company was founded in 2005 and is headquartered in Hamilton, Bermuda.

Earnings Per Share

As for profitability, DHT Holdings has a trailing twelve months EPS of $1.05.

PE Ratio

DHT Holdings has a trailing twelve months price to earnings ratio of 10.68. Meaning, the purchaser of the share is investing $10.68 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.27%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 22.9% and positive 57.9% for the next.

4. Hercules Technology Growth Capital (HTGC)

86.82% Payout Ratio

Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. The firm prefers to invest between $10 million to $250 million in equity per transactions. It invests generally between $1 million to $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in Connecticut; Boston, Massachusetts; San Diego, California; Westport, Connecticut; Elmhurst, Illinois; Santa Monica, California; McLean, Virginia; New York, New York; Radnor, Pennsylvania; and Washington, District of Columbia and London, United Kingdom.

Earnings Per Share

As for profitability, Hercules Technology Growth Capital has a trailing twelve months EPS of $2.2.

PE Ratio

Hercules Technology Growth Capital has a trailing twelve months price to earnings ratio of 8.9. Meaning, the purchaser of the share is investing $8.9 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.73%.

Volume

Today’s last reported volume for Hercules Technology Growth Capital is 588651 which is 32.65% below its average volume of 874096.

5. Simulations Plus (SLP)

46.15% Payout Ratio

Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for noncompartmental analysis and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher. In addition, it offers KIWI, a cloud-based web application to organize, process, maintain, and communicate the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; NAFLDsym, a simulation program for analyzing nonalcoholic fatty liver disease; RENAsym for investigating and predicting drug-induced or acute kidney injury; IPFsym, a software tool to treat or cure idiopathic pulmonary fibrosis; and the Monolix Suite, a solution for modeling and simulation. Further, the company provides population modeling and simulation contract research services; and clinical-pharmacology-based consulting services in support of regulatory submissions. It serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. The company was founded in 1996 and is headquartered in Lancaster, California.

Earnings Per Share

As for profitability, Simulations Plus has a trailing twelve months EPS of $0.52.

PE Ratio

Simulations Plus has a trailing twelve months price to earnings ratio of 92.6. Meaning, the purchaser of the share is investing $92.6 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.16%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Apr 26, 2024, the estimated forward annual dividend rate is 0.24 and the estimated forward annual dividend yield is 0.5%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 16.2%, now sitting on 64.67M for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 25% and positive 450% for the next.

Sales Growth

Simulations Plus’s sales growth for the next quarter is 28.2%.

1. 1 (1)

1% Payout Ratio

1

Earnings Per Share

As for profitability, 1 has a trailing twelve months EPS of $1.

PE Ratio

1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, 1’s stock is considered to be overbought (>=80).

Volatility

1’s last week, last month’s, and last quarter’s current intraday variation average was 1.00%, 1.00%, and 1.00%.

1’s highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).

Leave a Reply

Your email address will not be published. Required fields are marked *